FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022397287> ?p ?o ?g. }

• W2022397287 abstract "New multifunctional nanoconstructs using mesoporous Si particles (SiMPs) and polymeric hydrogel particles (HG) are synthesized with superior MRI efficacy and favorable pharmacokinetic properties. Clinically relevant Gd 3+ -based contrast agents (CAs) for magnetic resonance imaging (MRI), namely [Gd (DTPA)] 2− , [Gd (DOTA)] 1- and superparamagnetic iron oxide (SPIO) nanoparticles, were either i) encapsulated within the mesoporous structure of the SiMPs or ii) covalently attached to SiMPs and HGs. The size (from 400 to 2000 nm) and shape (discoidal, cylindrical, etc.) of the nanoconstructs are accurately tailored during the fabrication process to control the in vivo biodistribution. In tumor bearing mouse model, discoidal particles with a characteristic size of 1000 x 400 nm were found to accumulate at the tumor site more than other particles. The incorporation of clinically used, FDA approved CAs into the mesoporous structure of the SiMPs led to magnetic nanoconstructs exhibiting much higher relaxivities as compared to free CAs in solution. In particular, the relaxivity for [Gd (DTPA)] 2− and [Gd (DOTA)] −1 loaded SiMPs was measured to be ∼ 25 mM −1 s −1 , which is more than 6 times larger than the r 1 obtained for free CAs (∼ 4 mM −1 s −1 ). The pore size played a dominant role in that the relaxivity was observed to grow with a reduction in pore diameter: r 1 ∼ 24 mM −1 s −1 for small pore SiMPs (5-10 nm); and r 1 ∼ 10 mM −1 s −1 for huge pore SiMPs (30-40 nm). CAs covalently attached to SiMPs and HGs, exhibited no such dependence on pore sizes but provided comparable enhancement in r 1 . For SPIOs encapsulated in mesoporous SiMPs, a much larger enhancement in relaxivity was observed with r 2 ∼ 220 mM −1 s −1 for the resulting nanoconstructs against r 2 ∼ 11.2 mM −1 s −1 for free SPIOs. These results suggest that geometrical confinement into mesopores is a general strategy for enhancing the performance of both T 1 and T 2 MRI CAs. Intravenous injection of SPIO-loaded SiMPs in melanoma bearing mice decreased the contrast (T 2 -weigthed relaxation), confirming the high level of accumulation of these nanoconstructs at the tumor site. For the enhanced relaxivity and superior localization of imaging agents at the target site, the proposed nanoconstructs provide an ideal platform for early cancer detection by MRI. In addition, the easily functionalizable surface of these nanoconstructs render them the ability to perform cellular and molecular imaging using clinical MRI scanners. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 4295. doi:1538-7445.AM2012-4295" @default.
• W2022397287 created "2016-06-24" @default.
• W2022397287 creator A5004263811 @default.
• W2022397287 creator A5034935600 @default.
• W2022397287 creator A5035212343 @default.
• W2022397287 creator A5061631250 @default.
• W2022397287 creator A5067648727 @default.
• W2022397287 creator A5068635066 @default.
• W2022397287 creator A5075877548 @default.
• W2022397287 creator A5077856024 @default.
• W2022397287 date "2012-04-15" @default.
• W2022397287 modified "2023-09-25" @default.
• W2022397287 title "Abstract 4295: Multifunctional nanoconstructs for tumor visualization using contrast enhanced MRI" @default.
• W2022397287 doi "https://doi.org/10.1158/1538-7445.am2012-4295" @default.
• W2022397287 hasPublicationYear "2012" @default.
• W2022397287 type Work @default.
• W2022397287 sameAs 2022397287 @default.
• W2022397287 citedByCount "0" @default.
• W2022397287 crossrefType "proceedings-article" @default.
• W2022397287 hasAuthorship W2022397287A5004263811 @default.
• W2022397287 hasAuthorship W2022397287A5034935600 @default.
• W2022397287 hasAuthorship W2022397287A5035212343 @default.
• W2022397287 hasAuthorship W2022397287A5061631250 @default.
• W2022397287 hasAuthorship W2022397287A5067648727 @default.
• W2022397287 hasAuthorship W2022397287A5068635066 @default.
• W2022397287 hasAuthorship W2022397287A5075877548 @default.
• W2022397287 hasAuthorship W2022397287A5077856024 @default.
• W2022397287 hasConcept C115260700 @default.
• W2022397287 hasConcept C121332964 @default.
• W2022397287 hasConcept C126838900 @default.
• W2022397287 hasConcept C143409427 @default.
• W2022397287 hasConcept C150903083 @default.
• W2022397287 hasConcept C155672457 @default.
• W2022397287 hasConcept C161790260 @default.
• W2022397287 hasConcept C171250308 @default.
• W2022397287 hasConcept C178790620 @default.
• W2022397287 hasConcept C180577832 @default.
• W2022397287 hasConcept C185592680 @default.
• W2022397287 hasConcept C192562407 @default.
• W2022397287 hasConcept C202751555 @default.
• W2022397287 hasConcept C207001950 @default.
• W2022397287 hasConcept C23792430 @default.
• W2022397287 hasConcept C2777807558 @default.
• W2022397287 hasConcept C2778978742 @default.
• W2022397287 hasConcept C32546565 @default.
• W2022397287 hasConcept C46141821 @default.
• W2022397287 hasConcept C55493867 @default.
• W2022397287 hasConcept C62520636 @default.
• W2022397287 hasConcept C71924100 @default.
• W2022397287 hasConcept C82776694 @default.
• W2022397287 hasConcept C86803240 @default.
• W2022397287 hasConceptScore W2022397287C115260700 @default.
• W2022397287 hasConceptScore W2022397287C121332964 @default.
• W2022397287 hasConceptScore W2022397287C126838900 @default.
• W2022397287 hasConceptScore W2022397287C143409427 @default.
• W2022397287 hasConceptScore W2022397287C150903083 @default.
• W2022397287 hasConceptScore W2022397287C155672457 @default.
• W2022397287 hasConceptScore W2022397287C161790260 @default.
• W2022397287 hasConceptScore W2022397287C171250308 @default.
• W2022397287 hasConceptScore W2022397287C178790620 @default.
• W2022397287 hasConceptScore W2022397287C180577832 @default.
• W2022397287 hasConceptScore W2022397287C185592680 @default.
• W2022397287 hasConceptScore W2022397287C192562407 @default.
• W2022397287 hasConceptScore W2022397287C202751555 @default.
• W2022397287 hasConceptScore W2022397287C207001950 @default.
• W2022397287 hasConceptScore W2022397287C23792430 @default.
• W2022397287 hasConceptScore W2022397287C2777807558 @default.
• W2022397287 hasConceptScore W2022397287C2778978742 @default.
• W2022397287 hasConceptScore W2022397287C32546565 @default.
• W2022397287 hasConceptScore W2022397287C46141821 @default.
• W2022397287 hasConceptScore W2022397287C55493867 @default.
• W2022397287 hasConceptScore W2022397287C62520636 @default.
• W2022397287 hasConceptScore W2022397287C71924100 @default.
• W2022397287 hasConceptScore W2022397287C82776694 @default.
• W2022397287 hasConceptScore W2022397287C86803240 @default.
• W2022397287 hasLocation W20223972871 @default.
• W2022397287 hasOpenAccess W2022397287 @default.
• W2022397287 hasPrimaryLocation W20223972871 @default.
• W2022397287 hasRelatedWork W1913796808 @default.
• W2022397287 hasRelatedWork W1968582239 @default.
• W2022397287 hasRelatedWork W1994640985 @default.
• W2022397287 hasRelatedWork W2035818744 @default.
• W2022397287 hasRelatedWork W2049721521 @default.
• W2022397287 hasRelatedWork W2075011308 @default.
• W2022397287 hasRelatedWork W2094073088 @default.
• W2022397287 hasRelatedWork W2150453394 @default.
• W2022397287 hasRelatedWork W2242244429 @default.
• W2022397287 hasRelatedWork W2299254898 @default.
• W2022397287 hasRelatedWork W2316749632 @default.
• W2022397287 hasRelatedWork W2324688637 @default.
• W2022397287 hasRelatedWork W2553481915 @default.
• W2022397287 hasRelatedWork W2609728518 @default.
• W2022397287 hasRelatedWork W2755201513 @default.
• W2022397287 hasRelatedWork W2782634481 @default.
• W2022397287 hasRelatedWork W2795017962 @default.
• W2022397287 hasRelatedWork W2883908631 @default.
• W2022397287 hasRelatedWork W3045321310 @default.
• W2022397287 hasRelatedWork W3119262624 @default.
• W2022397287 isParatext "false" @default.
• W2022397287 isRetracted "false" @default.

• next